U.S. FDA approves landmark pancreatic cancer drug that’s shown to improve survival

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.